At this year´s Medicon Valley Alliance Ordinary General Meeting, Thursday 16th of April, which was organized as an online meeting, the MVA Board of Directors had the pleasure of welcoming, Linn Mandahl, General Manager, AbbVie Scandinavia as a new board member. In addition, Malmö University, upgraded its membership and will in the future have a permant seat in the board along with the representatives from University of Copenhagen and Lund University. Chairman, Søren Bregenholt (CEO, Macrophage Pharma) and vice chairman, Ulf Andersson, (CEO Medeon Science Park) were both reelected.
With more than 50 new member companies and organisations having joined us during 2019, Medicon Valley Alliance, has now reached an alltime high of +300 members.
– We are on the right track, we have initiated strategic collaboration projects within for instance diabetes and microbiome worth more than 14 million € and we experience a growing interest in MVA events and activities. This gives us good reason for optimism, and as soon as the situation normalizes somewhat, I am sure we will be well-positioned to continue our efforts to develop and promote the cluster even further. It is still our explicit ambition to make Medicon Valley the strongest life science cluster in Northern Europe, says, Petter Hartman, CEO, Medicon Valley Alliance.